Alexandra Bause, PhD
Alexandra has always considered her life goal to contribute to developing and advancing novel therapies, particularly against age-related diseases. With Apollo she will leverage her scientific and strategic expertise to support new ventures in the development of groundbreaking therapies.
Before Apollo Alexandra was a consultant with The Boston Consulting Group in Munich, where she specialized in buy- and sell-side asset valuations for biotechnology companies and biopharma portfolio strategy. Her PhD studies at Harvard Medical School were focused on investigating the molecular mechanisms that contribute to cellular aging and could be targeted to increase mammalian health span. She is also a trained pharmacist with expertise in pharmacology and toxicology.